THTX (Theratechnologies Inc.) Forward P/E Multiple

Corporate company logo of Theratechnologies Inc (THTX)

This Theratechnologies Inc. (THTX) trading chart, with the metric at 0.00, demonstrates the dynamics of a company implementing digital control over logistics and medical data. The business is based on developing HIV treatments through cooperation with scientific centers, as well as providing patients globally with essential medications.

Projected Price to Earnings: Theratechnologies (THTX) for 07/04/2022 - 10/11/2025

Analytical breakdowns for Theratechnologies Inc.

- current price and projected stock value:
Summary company analytics:theratech.com
Product sample of Theratechnologies Inc.

Theratechnologies Inc. develops high-tech drugs for oncology and HIV therapy, leveraging the intellectual capital of biochemists. Valuing these developments via the company's forward P/E links market capitalization to projected net income. This metric determines the return on investment coefficient by comparing the current share price with expected earnings. High values indicate inflated market expectations, while low values suggest undervaluation. By analyzing the forward P/E of Theratechnologies Inc., an investor determines the business's resilience to stagnation.

Competitors of Theratechnologies Inc. (THTX)

Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|VTYX (ventyxbio.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Avalo Therapeutics AVTX|Forward P/E Multiple ELDN|AGEN (Agenus, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Projected Price to Earnings Ratio|ATYR: Projected Price to Earnings|adagene.com (ADAG) - Projected Price to Earnings|Ikena Oncology (IMA) - Future Price to Earnings|Projected Price to Earnings Shattuck Labs, Inc.|Future Price to Earnings equilliumbio.com|Projected Price to Earnings connectbiopharm.com (CNTB)|Forward P/E Multiple IMUX|Market Cap to Projected Earnings Atara Bio|Future Price to Earnings InflaRx N.V. IFRX|X4 Pharmaceuticals - Future Price to Earnings|ACET: Projected Price to Earnings|Future Price to Earnings Multiple CELU (celularity.com)|INMB: Forward P/E Multiple|BRNS: Market Cap to Future Earnings Ratio|KZR (Kezar Life Sciences, Inc.) - Forward P/E Multiple|SAB Biotherapeutics Inc. (SABS) - Market Cap to Projected Earnings|Forward P/E Multiple AKTX|Future Price to Earnings ENLV (Enlivex Therapeutics Ltd)|Future Price to Earnings Q32 Bio Inc. QTTB|GOVX - Projected Price to Earnings|EDSA - Future Price to Earnings|Projected Price to Earnings Ratio iBio|CARM: Forward P/E Multiple|Price to Expected Earnings Ratio XTLB (XTL Biopharmaceuticals, Ltd.)|Future Price to Earnings boltbio.com|Forward P/E Multiple HCW Biologics|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple